Integrity Implant System Post Market Clinical Follow-Up Study
NCT ID: NCT06741527
Last Updated: 2025-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
150 participants
INTERVENTIONAL
2025-02-01
2027-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The clinical success will be evaluated by absence of rotator cuff re-tear. Performance and clinical benefits will be evaluated by functional outcomes measured using standard scoring systems such as the American Shoulder and Elbow Surgeons Shoulder Score (ASES), Constant-Murley Score (CMS), Patient Satisfaction, EQ-5D-5L, Single Assessment Numeric Evaluation (SANE), Visual Analogue Scale (VAS) and rotator cuff repair outcomes measured using MRI evaluation for repair integrity, quality, tendon tissue thickness and regeneration.
Safety of the Integrity Implant System will be assessed by monitoring the frequency and incidence of adverse events.
The Primary Endpoint shall confirm the Performance of the Integrity Implant System when used for rotator cuff augmentation (with or without repair). Performance will be evaluated by an adequately powered analysis of retear rates seen by MRI at 12-months after surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Integrity Implant System
Integrity Implant System
Integrity Implant System used for Rotator Cuff Repair
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Integrity Implant System
Integrity Implant System used for Rotator Cuff Repair
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
2. Vulnerable population (prisoners, minors, pregnant women, mentally ill persons and the elderly or any person under any undue pressure from others to participate in the study)
3. Pregnant, breastfeeding, or plans to become pregnant during the study
4. History of poor compliance with medical treatment of any kind
5. Deemed contraindicated for MRI by the PI
6. Previous rotator cuff surgery (any type) on the index shoulder
7. Current instability of the index shoulder
8. Rotator cuff tendon tear is a Massive Cofield Classified Full-Thickness Tear (tear length \>5cm)
9. Chondromalacia of index shoulder ≥ Grade 3
10. Fatty infiltration of the index shoulder rotator cuff muscle ≥ Grade 3
11. Insulin dependent Type I Diabetes
12. History of heavy smoking (≥ 1 pack per day) within last 6-months
13. History of auto-immune or immunodeficiency disorders
14. Currently taking immunosuppression medication for other diseases (e.g., transplants or other inflammatory diseases)
15. Oral steroid use in the last 2-months or injectable steroid use in the last 3-months
16. History of cognitive or mental health status that interferes with study participation
17. Poor comprehension of English language
18. Meets one or more of the contraindications defined within the Integrity Implant System IFUs as applied to rotator cuff tendon tears. These include:
18.1 Rotator cuff tendon tear is deemed irreparable by the PI
18.2 Rotator cuff tendon tear repair requires replacement of damaged tendon
18.3 Rotator cuff tendon tear repair requires fixation of soft tissue to adjoining soft tissue
18.4 Rotator cuff tendon tear repair requires tendon strength reinforcement
18.5 Presence of infection
18.6 Any condition which would limit the ability or willingness to restrict activities or follow directions during the healing period
18.7 Hypersensitivity to any of the Integrity Implant System components
18.8 Inadequate soft tissue support for Integrity Tissue Tack fixation
18.9 Inadequate quality of bone for Integrity Bone Staple fixation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anika Therapeutics, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Foundation for Orthopaedic Research and Education
Tampa, Florida, United States
Central Indiana Orthopaedics
Fishers, Indiana, United States
Towson Orthopaedic Associates/University of Maryland St. Joseph's Medical Center
Towson, Maryland, United States
Virtua Health
Marlton, New Jersey, United States
Steadman Hawkins Clinic of the Carolinas
Greenville, South Carolina, United States
Campbell Clinic
Germantown, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Debbi Warren, RN
Role: primary
Peter Simon, PhD
Role: backup
Brad Crackel, ATC
Role: primary
Derek Yocum, PhD
Role: backup
Casey M Codd
Role: primary
Debbie K Codd
Role: backup
Donna Hoopes
Role: primary
Kristin Broderick
Role: backup
Allison Nall, MS
Role: primary
Allyson Sandago
Role: backup
Lucy Del Mar, MD
Role: primary
Margaret Knack, RN
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Protocol 24-01
Identifier Type: -
Identifier Source: org_study_id